China Medical Technologies to Announce Results for the Third Fiscal Quarter Ended December 31, 2010 on February 18, 2011
BEIJING, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 3...
China Medical Technologies, Inc. Announces the Closing of US$150 Million Convertible Senior Note Offering and the Completion of Repurchase of US$105.9 Million Convertible Notes Due 2011
BEIJING, Dec. 6, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has closed the private offering of US$150 million in aggregate principal amount of convert...
China Medical Technologies Announces its Subsidiaries, GP Medical and Beijing Yuande, Ranked 12th and 415th, respectively, in Deloitte Technology Fast 500 Asia Pacific 2010 Program
BEIJING, Dec. 6, 2010 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that its wholly-owned subsidiaries, Beijing GP Medical Technologies Co., Ltd. ("GP Medical") and Beijing Yua...
China Medical Technologies, Inc. Announces Pricing of US$125 Million Convertible Senior Notes
BEIJING, Dec. 1, 2010 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30,...
China Medical Technologies, Inc. Announces Proposed Private Offering of US$100 Million Convertible Senior Notes
BEIJING, Nov. 29, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it proposes to offer, subject to market and other conditions, up to US$100 million in aggreg...
China Medical Technologies Announces Signing of Respective Strategic Collaboration Agreement with Standard Chartered Bank (China) Limited and Guangdong Development Bank
BEIJING, Nov. 23, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has signed a strategic collaboration agreement with Standard Chartered Bank (China) Limit...
China Medical Technologies Reports Second Fiscal Quarter Financial Results
BEIJING, Nov. 17, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the second fiscal quarter ended September 30, 2010 ("2Q FY201...
China Medical Technologies Receives SFDA Approval for its First Self-Developed PCR-based EGFR Assay for Lung Cancer Targeted Drugs
BEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its real-time PCR-based Epidermal Growth Factor Receptor ("EGFR...
China Medical Technologies to Announce Results for the Second Fiscal Quarter Ended September 30, 2010 on November 17, 2010
BEIJING, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the second fiscal quarter ended September ...
China Medical Technologies to Participate in Investor Conferences in November 2010
BEIJING, Nov. 2, 2010 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will participate at the following investor conferences in November 2010: Investor Conference Date L...
China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
BEIJING, Oct. 22 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that its subsidiary, Beijing GP Medical Technologies Co., Ltd. ("GP Medical"), has been ranked sixth in...
China Medical Technologies Files its Annual Report on Form 20-F for the Fiscal Year Ended March 31, 2010 with the SEC
BEIJING, Sept. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced the filing of its annual report on Form 20-F for the fiscal year ended March 31, 2010 with the U.S....
China Medical Technologies Reports First Fiscal Quarter Financial Results
BEIJING, Aug. 16 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the first fiscal quarter ended June 30, 2010 ("1Q FY2010"). 1Q FY2010 ...
China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health
BEIJING, July 15 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that its HER-2 FISH probe has been chosen to be used in a research project focusing on cancer targeted therap...
China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2010 on August 16, 2010
BEIJING, July 2 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the first fiscal quarter ("1Q FY2010") ended June 30, ...
China Medical Technologies Announces the Recent Publication of a Study on its SPR Analyzer and HPV DNA Chip in Cancer Genetics and Cytogenetics and the Creation of a Medical Publications Column to the Investor Relations Section on its Website
BEIJING, June 29 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced the recent publication of a large sample study on the Company's SPR analyzer and related HPV DNA ch...
China Medical Technologies Receives SFDA Approval for its SPR-based HPV-DNA Chip
BEIJING, June 9 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its SPR-based HPV-DNA chip (the "HPV Chip") from the State Foo...
China Medical Technologies Reports Financial Results for Fourth Fiscal Quarter and Full Year ended March 31, 2010
BEIJING, June 4 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the fourth fiscal quarter ("4Q FY2009") and the full fiscal year ended Mar...
China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
BEIJING, April 30 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the fourth fiscal quarter ("4Q FY2009") and the fisc...
China Medical Technologies Receives SFDA Approval for its Fully-Automated ECLIA Analyzer (AUTOMAGLIA 90) and SFDA Approval for its Down Syndrome Screening Kit
BEIJING, April 29 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer ("AUTOMAGLIA 90 Analyzer") as...
